Indication
Post-COVID Syndrome
5 clinical trials
5 products
1 drug
Product
RegeneCyteClinical trial
A Randomized Controlled Phase IIa, Two-arm Study to Assess the Safety and Efficacy of Human Umbilical Cord Blood (RegeneCyte) Infusion in Patients With Post-COVID SyndromeStatus: Recruiting, Estimated PCD: 2024-10-01
Clinical trial
Hyperbaric Oxygen for Treatment of Long COVID Syndrome; A Randomized, Placebo-Controlled, Double-Blind, Phase II Clinical TrialStatus: Active (not recruiting), Estimated PCD: 2023-09-27
Product
Hyperbaric oxygenProduct
Synthetic Vitamin B1Clinical trial
Evaluating the Effectiveness of Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Post-Acute Sequelae of SARS-CoV-2 (PASC)Status: Active (not recruiting), Estimated PCD: 2023-06-15
Product
Stellate Ganglion BlockClinical trial
An Interventional, Double-Blinded, 2-Arm Study to Investigate the Efficacy of Orally Administered Nirmatrelvir/Ritonavir Compared With Placebo/Ritonavir in Non-hospitalized Adult Participants Suffering From Post-COVIDStatus: Recruiting, Estimated PCD: 2024-01-31
Product
Placebo/ritonavir